Content
All Posts > Content under Press Releases/IR
10 Compelling Reason To Buy This Rare Earths Company
Article By:
Epstein-Research
Read
Wednesday, April 22, 2015 9:05 AM EDT
Ucore is a development-stage is an Alaskan REE company focused on near-term production. 40% (by weight) of the REE are Heavy Rare Earth Elements, “HREE.” The company's MRT technology could be a game-changer in the REE sector.
In this article: UURAF
Celanese Corporation Reports Record Quarterly Results
Article By:
Business Wire
Read
Thursday, April 16, 2015 9:52 PM EDT
CE raises 2015 adjusted earnings outlook range to $5.60 to $5.90 per share.
In this article: CE
American Express First Quarter EPS Of $1.48, Up 11% From A Year Ago
Article By:
Business Wire
Read
Thursday, April 16, 2015 6:15 PM EDT
Higher card member spending and loans drive core performance; operating expenses remain well controlled.
In this article: AXP
Arabcom Group Hosts “14th Special Edition” Of MENA Forex Expo On April 9-10, 2015
Article By:
Arabcom Group
Read
Wednesday, April 8, 2015 4:18 PM EDT
The MENA Forex managed funds and investment show is the largest online trading exhibition, conference and awards event in the Middle East and North Africa.
Ucore's HREE CEO Is Very Bullish On Near-Term Developments
Article By:
Peter Epstein
Read
Tuesday, March 31, 2015 2:32 PM EDT
Any time a new and disruptive technology is introduced, the initial reaction is denial. Separating the lanthanide suite of metals, without expensive & environmentally invasive Solvent Extraction, is the holy grail of the REE sector. The MRT technology has a long pedigree in metals processing.
In this article: UURAF
PTBI Announces Initiation Of Enrollment Of MuGard® Trial For Afinitor®; IRWD Initiates Phase I Clinical Study Of IW-1973
Article By:
BioMedReports
Read
Friday, March 6, 2015 4:02 AM EDT
PTBI, announced enrollment has begun in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center. IRWD announced dosing has begun in a Phase I clinical study of IW-1973, the first clinical compound in a broad.
ADMP Announces Positive Results For Its Dry Powder Inhaler Product; BOTA Commences Dosing In Vapendavir Phase 2b Trial
Article By:
BioMedReports
Read
Wednesday, March 4, 2015 5:15 AM EDT
ADMP announced the results of its pharmacokinetic (PK) study for its dry powder inhaler product, APC-5000. BOTA announced it has commenced dosing of patients in its Phase 2b SPIRITUS trial of vapendavir.
Shares Of Vitae Are Down 30% After Hours After Its Partner Places Alzheimer's Trial On A Voluntary Hold
Article By:
Terry Chrisomalis
Read
Thursday, February 26, 2015 8:20 PM EDT
Vitae's partner, Boehringer Ingelheim, has decided to halt its Alzheimers trial until it resolves safety problems
In this article: VTAE
J.C. Penney Reports $1.1 Billion Increase In Ebitda For Fiscal 2014
Article By:
TalkMarkets DailyTalk
Read
Thursday, February 26, 2015 5:40 PM EDT
After-hours, stock loses most of last few days' gains.
In this article: JCPNQ
Salesforce Announces Fiscal 2015 Fourth Quarter And Full Year Results
Article By:
PR Newswire
Read
Wednesday, February 25, 2015 6:08 PM EDT
Salesforce delivered another year of exceptional growth, with revenue, deferred revenue and operating cash flow all growing more than 30%. Positive results wipe out yesterday's losses and set 52-week high after hours.
In this article: CRM
Horizon X2 Aircraft Investment Idea
Article By:
Chris Vermeulen
Read
Wednesday, February 25, 2015 5:45 PM EDT
If you're an aviation buff like me, you might be intrigued by this new airplane.
Rigel Pharmaceuticals, Inc. Surges 39% On Agreement With Bristol-Myers Squibb
Article By:
BioMedReports
Read
Monday, February 23, 2015 7:42 PM EDT
Following the surge in stock price, here is what you need to know about Rigel's latest development.
FDA Expands Indication For Revlimid
Article By:
Business Wire
Read
Wednesday, February 18, 2015 12:40 PM EDT
Celgene today announced that the FDA has expanded the existing indication for Revlimid® (lenalidomide) in combination with dexamethasone to include patients newly diagnosed with multiple myeloma.
In this article: CELG
NEPT Shareholders Approve Arrangement With Neptune; Aileron Initiates Phase 1 Cancer Study Of ALRN-6924
Article By:
BioMedReports
Read
Friday, February 13, 2015 4:59 AM EDT
NEPT shareholders (the "Shareholders") approved a resolution today authorizing the previously announced plan of arrangement providing for, among other things, the indirect acquisition by Neptune of all of the issued and outstanding shares of NeuroBio.
In this article: NEPT
Kraft Announces Leadership Changes
Article By:
PR Newswire
Read
Thursday, February 12, 2015 8:32 PM EDT
After a largely positive earnings report led by the Cheese group, Kraft announces a shakeup at the top.
In this article: KRFT